Quantum Genomics SA (ALQGC) — Cash Flow-to-Debt Ratio
Latest as of June 2023:
-1.85x
Quantum Genomics SA (ALQGC) has a Cash Flow-to-Debt Ratio of -1.85x as of June 2023, meaning its operating cash flow of €-7.64 Million could theoretically repay -2% of its total liabilities (€4.13 Million) in one year. See ALQGC financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-1.85x
Operating CF / Total Liabilities
Operating Cash Flow
€-7.64 Million
EUR
Total Liabilities
€4.13 Million
EUR
Data as of
Jun 2023
Most recent filing
Quantum Genomics SA Cash Flow-to-Debt Ratio (2012–2022)
Historical debt coverage capacity for Quantum Genomics SA across 11 annual periods. For the full cash flow conversion analysis, see Quantum Genomics SA (ALQGC) cash conversion ratio.
Annual Cash Flow-to-Debt Ratio for Quantum Genomics SA (2012–2022)
Year-by-year debt coverage analysis for Quantum Genomics SA.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2022 | -1.01x | €-20.21 Million | €20.05 Million | ▲ +31.4% |
| 2021 | -1.47x | €-17.02 Million | €11.57 Million | ▲ +0.1% |
| 2020 | -1.47x | €-11.99 Million | €8.15 Million | ▲ +24.2% |
| 2019 | -1.94x | €-10.43 Million | €5.37 Million | ▼ -17.7% |
| 2018 | -1.65x | €-10.90 Million | €6.61 Million | ▼ -4.3% |
| 2017 | -1.58x | €-7.98 Million | €5.05 Million | ▲ +22.3% |
| 2016 | -2.04x | €-5.53 Million | €2.72 Million | ▼ -63.2% |
| 2015 | -1.25x | €-3.14 Million | €2.52 Million | ▼ -118.3% |
| 2014 | -0.57x | €-2.79 Million | €4.88 Million | ▼ -92.4% |
| 2013 | -0.30x | €-987.00K | €3.32 Million | ▲ +4.4% |
| 2012 | -0.31x | €-614.00K | €1.97 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.